News

Vironova’s Director Human Resources, Ann Fredriksson, will be one of a handful members of a new task force put together by SwedenBIO. The cross-organizational group will focus on finding solutions to current human resource challenges in the Nordic...

Vironova Medical AB, a spin off from Vironova AB, have developed an antiviral drug candidate against SARS-CoV-2. A novel class of antiviral drugs against covid-19/SARS-CoV-2, first evaluated in vitro against SARS-CoV-2 virus at the University of...

The SARS-CoV-2 pandemic has had a significant negative impact on the world’s public health and the global economy since its outbreak in the beginning of 2020. From this has the international MAD-CoV 2 project emerged, trying to provide an increased...

Stockholm, 1st of December 2020. A message from our CEO, Mohammed Homman. I am very pleased to announce a new strategic partnership between Vironova and a top-tier management consultancy1, focusing on accelerating Vironova’s growth and valuation.

Congratulations from all Vironovians, and especially from our R&D team to our collaborators in the HASTE team, winning the AI cell analysis challenge organized by AI Sweden AI Sweden and AstraZeneca in fierce international competition!

Watch our on demand webinar and download the presentation from November 3rd, where we together with BioPharma Asia and Biogen gave guidance and our view on possible solutions for "Analytical Challenges for Gene Therapy", and how can you overcome...

Vironova is now searching for a Life Sciences Application Specialist to act both as a consultant and trainer for customers and as an internal technical resource, exploring opportunities to develop analytical insights through the proper use of...

Webinar 3rd of November covering "Analytical Challenges for Gene Therapy", and how can you overcome these. Sign up at BioPharma Asia's website and deep dive into the topic where our colleague Dr Saba Hussein Gore together with BioPharma Asia and...

Tailor-made, activity-based, state-of-the-art premises in all their glory - but the foundation of tomorrow´s organization and workplace is more than ever based on the employees and a value driven corporate culture, according to Vironova's founder...

A short interview to bring you back stage of Vironova with Dr. Josefina Nilsson, our Head of Business Unit, Electron Microscopy Services who delves into the unique benefits of transmission electron microscopy (TEM); the importance of TEM analysis in...